CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 83 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2018. The put-call ratio across all filers is 1.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $363,000 | +188.1% | 290,532 | +314.9% | 0.00% | +50.0% |
| Q3 2020 | $126,000 | -89.7% | 70,026 | -51.8% | 0.00% | -90.0% |
| Q2 2020 | $1,218,000 | +859.1% | 145,140 | +455.1% | 0.02% | +1900.0% |
| Q3 2019 | $127,000 | -13.6% | 26,148 | +8.4% | 0.00% | -50.0% |
| Q1 2018 | $147,000 | -33.5% | 24,126 | -22.5% | 0.00% | -50.0% |
| Q4 2017 | $221,000 | +234.8% | 31,127 | +197.0% | 0.00% | +300.0% |
| Q2 2017 | $66,000 | – | 10,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $42,335,000 | 24.44% |
| MANGROVE PARTNERS IM, LLC | 552,200 | $4,633,000 | 1.13% |
| ETF MANAGERS GROUP, LLC | 3,707,912 | $31,109,000 | 1.10% |
| Ikarian Capital, LLC | 1,350,000 | $11,327,000 | 0.90% |
| GENERAL AMERICAN INVESTORS CO INC | 712,400 | $5,977,000 | 0.76% |
| AdvisorShares Investments LLC | 189,814 | $1,593,000 | 0.68% |
| Ikarian Capital, LLC | 1,000,000 | $8,390,000 | 0.67% |
| Granite Point Capital Management, L.P. | 1,123,600 | $9,427,000 | 0.48% |
| Carmignac Gestion | 3,773,440 | $31,659,000 | 0.44% |
| Omnia Family Wealth, LLC | 32,356 | $271,467,000 | 0.27% |